NEUROTERA: For the placing on the market of new therapeutic agents against ocular and cerebral comorbidities associated with paramyloidosis (Q2907213): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed label, description and/or aliases in pt, en, de, nl, it, es, et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, da, ro, sv, fr, and other parts: Adding translations: et, lt, it, fr, hr, el, en, sk, fi, pl, hu, nl, cs, lv, ga, sl, es, bg, mt, pt, da, ro, de, sv,)
(‎Added qualifier: readability score (P590521): 0.000011549073841409742)
 
(5 intermediate revisions by the same user not shown)
label / ptlabel / pt
None
NEUROTERA .: Para a introdução no mercado de novos agentes terapêuticos contra co-morbilidades oculares e cerebrais associadas à Paramiloidose
label / enlabel / en
None
NEUROTERA: For the placing on the market of new therapeutic agents against ocular and cerebral comorbidities associated with paramyloidosis
Property / beneficiary name (string)
BSIM THERAPEUTICS, S.A.
 
Property / beneficiary name (string): BSIM THERAPEUTICS, S.A. / rank
Normal rank
 
Property / beneficiary
Q2988326 (Deleted Item)
 
Property / beneficiary: Q2988326 (Deleted Item) / rank
Normal rank
 
Property / budget
1,136,308.0 Euro
Amount1,136,308.0 Euro
UnitEuro
 
Property / budget: 1,136,308.0 Euro / rank
Normal rank
 
Property / EU contribution
891,221.0 Euro
Amount891,221.0 Euro
UnitEuro
 
Property / EU contribution: 891,221.0 Euro / rank
Normal rank
 
Property / co-financing rate
78.43 percent
Amount78.43 percent
Unitpercent
 
Property / co-financing rate: 78.43 percent / rank
Normal rank
 
Property / summary: None (English) / qualifier
 
readability score: 0.000011549073841409742
Amount0.000011549073841409742
Unit1
Property / priority axis
 
Property / priority axis: Strengthening research, technological development and innovation (OT1) / rank
 
Normal rank
Property / thematic objective
 
Property / thematic objective: Research and innovation / rank
 
Normal rank
Property / beneficiary
 
Property / beneficiary: BSIM THERAPEUTICS, S.A. / rank
 
Normal rank
Property / beneficiary name (string)
 
BSIM THERAPEUTICS, S.A.
Property / beneficiary name (string): BSIM THERAPEUTICS, S.A. / rank
 
Normal rank
Property / budget
 
934,289.9 Euro
Amount934,289.9 Euro
UnitEuro
Property / budget: 934,289.9 Euro / rank
 
Preferred rank
Property / EU contribution
 
722,832.3 Euro
Amount722,832.3 Euro
UnitEuro
Property / EU contribution: 722,832.3 Euro / rank
 
Preferred rank
Property / co-financing rate
 
77.37 percent
Amount77.37 percent
Unitpercent
Property / co-financing rate: 77.37 percent / rank
 
Normal rank
Property / date of last update
 
14 November 2023
Timestamp+2023-11-14T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / date of last update: 14 November 2023 / rank
 
Normal rank

Latest revision as of 13:21, 20 March 2024

Project Q2907213 in Portugal
Language Label Description Also known as
English
NEUROTERA: For the placing on the market of new therapeutic agents against ocular and cerebral comorbidities associated with paramyloidosis
Project Q2907213 in Portugal

    Statements

    0 references
    722,832.3 Euro
    0 references
    934,289.9 Euro
    0 references
    77.37 percent
    0 references
    16 August 2016
    0 references
    15 February 2020
    0 references
    BSIM THERAPEUTICS, S.A.
    0 references
    None (Estonian)
    29 July 2022
    0 references
    None (Lithuanian)
    29 July 2022
    0 references
    None (Italian)
    29 July 2022
    0 references
    None (French)
    29 July 2022
    0 references
    None (Croatian)
    29 July 2022
    0 references
    None (Greek)
    29 July 2022
    0 references
    None (English)
    29 July 2022
    0.000011549073841409742
    0 references
    None (Slovak)
    29 July 2022
    0 references
    None (Finnish)
    29 July 2022
    0 references
    None (Polish)
    29 July 2022
    0 references
    None (Hungarian)
    29 July 2022
    0 references
    None (Dutch)
    29 July 2022
    0 references
    None (Czech)
    29 July 2022
    0 references
    None (Latvian)
    29 July 2022
    0 references
    None (Irish)
    29 July 2022
    0 references
    None (Slovenian)
    29 July 2022
    0 references
    None (Spanish)
    29 July 2022
    0 references
    None (Bulgarian)
    29 July 2022
    0 references
    None (Maltese)
    29 July 2022
    0 references
    None (Portuguese)
    29 July 2022
    0 references
    None (Danish)
    29 July 2022
    0 references
    None (Romanian)
    29 July 2022
    0 references
    None (German)
    29 July 2022
    0 references
    None (Swedish)
    29 July 2022
    0 references
    14 November 2023
    0 references

    Identifiers

    POCI-01-0247-FEDER-003431
    0 references